Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Gunn George W
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2017-06-30−500→ 1,500 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying) - Exercise/Conversion
Restricted Stock Units
2017-07-01−3,600→ 0 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying) - Exercise/Conversion
Ordinary Shares
2017-06-30$0.13/sh+500$63→ 39,000 total - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+3,600$450→ 42,600 total
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 6/30/17, and 500 Restricted Share Units shall vest and become convertible on each of 9/30/17, 12/31/17 and 3/31/18 in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.